HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids.

AbstractBACKGROUND:
Patients with systemic lupus erythematosus (SLE) are at increased risk of atherosclerosis, even after accounting for traditional risk factors. High levels of leptin and low levels of adiponectin are associated with both atherosclerosis and immunomodulatory functions in the general population.
OBJECTIVE:
To examine the association between these adipokines and subclinical atherosclerosis in SLE, and also with other known inflammatory biomarkers of atherosclerosis.
METHODS:
Carotid ultrasonography was performed in 250 women with SLE and 122 controls. Plasma leptin and adiponectin levels were measured. Lipoprotein a (Lp(a)), oxidised phospholipids on apoB100 (OxPL/apoB100), paraoxonase, apoA-1 and inflammatory high-density lipoprotein (HDL) function were also assessed.
RESULTS:
Leptin levels were significantly higher in patients with SLE than in controls (23.7±28.0 vs 13.3±12.9 ng/ml, p<0.001). Leptin was also higher in the 43 patients with SLE with plaque than without plaque (36.4±32.3 vs 20.9±26.4 ng/ml, p=0.002). After multivariate analysis, the only significant factors associated with plaque in SLE were leptin levels in the highest quartile (≥29.5 ng/ml) (OR=2.8, p=0.03), proinflammatory HDL (piHDL) (OR=12.8, p<0.001), age (OR=1.1, p<0.001), tobacco use (OR=7.7, p=0.03) and hypertension (OR=3.0, p=0.01). Adiponectin levels were not significantly associated with plaque in our cohort. A significant correlation between leptin and piHDL function (p<0.001), Lp(a) (p=0.01) and OxPL/apoB100 (p=0.02) was also present.
CONCLUSIONS:
High leptin levels greatly increase the risk of subclinical atherosclerosis in SLE, and are also associated with an increase in inflammatory biomarkers of atherosclerosis such as piHDL, Lp(a) and OxPL/apoB100. High leptin levels may help to identify patients with SLE at risk of atherosclerosis.
AuthorsMaureen McMahon, Brian J Skaggs, Lori Sahakian, Jennifer Grossman, John FitzGerald, Nagesh Ragavendra, Christina Charles-Schoeman, Marissa Chernishof, Alan Gorn, Joseph L Witztum, Weng Kee Wong, Michael Weisman, Daniel J Wallace, Antonio La Cava, Bevra H Hahn
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 70 Issue 9 Pg. 1619-24 (Sep 2011) ISSN: 1468-2060 [Electronic] England
PMID21670088 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Adipokines
  • Biomarkers
  • Inflammation Mediators
  • Leptin
  • Lipids
Topics
  • Adipokines (blood)
  • Adult
  • Atherosclerosis (blood, diagnostic imaging, etiology)
  • Biomarkers (blood)
  • Body Mass Index
  • Carotid Artery, Common (diagnostic imaging)
  • Epidemiologic Methods
  • Female
  • Humans
  • Inflammation Mediators (blood)
  • Leptin (blood)
  • Lipids (blood)
  • Lupus Erythematosus, Systemic (blood, complications)
  • Middle Aged
  • Oxidation-Reduction
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: